SARS-CoV-2 in the abdomen or pelvis: SAFE SURGERY study
Br J Surg
.
2023 Feb 15;110(3):306-309.
doi: 10.1093/bjs/znac297.
Authors
Dale Vimalachandran
1
,
Robert P Jones
2
,
Ed Dickson
3
,
Jaspreet Seehra
3
,
Austin Acheson
3
,
Ewen A Griffiths
4
,
Sivesh Kamarajah
4
,
Elaine Leung
5
,
Andrew Torrance
6
,
Christian Ottensmeier
7
,
Andrew D Beggs
4
5
,
Ellen Whiteside
8
,
Helen Sanna
8
,
Danielle Bury
8
,
Esther Youd
9
,
Gareth Leopold
10
,
Matthew Pugh
11
,
Sudha Sundar
5
,
Graham S Taylor
11
Affiliations
1
Department of General and Colorectal Surgery, Countess of Chester NHS Trust, Chester, UK.
2
Department of General and Hepatobiliary Surgery, Liverpool University Hospital NHS Trust, Liverpool, UK.
3
Department of General and Colorectal Surgery, Nottingham University Hospitals NHS Trust, Nottingham, UK.
4
Upper GI Unit, University Hospitals Birmingham NHS Trust, Birmingham, UK.
5
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
6
Department of General and Colorectal Surgery, Sandwell and West Birmingham NHS Trust, City Hospital,, Birmingham, UK.
7
Liverpool Head and Neck Centre, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK.
8
Department of Molecular Pathology, Blackpool Victoria Hospital NHS Trust, Blackpool, UK.
9
Department of Pathology, Royal Glamorgan Hospital, Cwm Taf University Health Board, Llantrisant, UK.
10
Department of Cellular Pathology, Morriston Hospital, Swansea Bay University Health Board, Swansea, UK.
11
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
PMID:
36168210
PMCID:
PMC9620655
DOI:
10.1093/bjs/znac297
No abstract available
MeSH terms
Abdomen / surgery
COVID-19*
Humans
Pelvis / surgery
SARS-CoV-2*
Grants and funding
MR/T001755/1/MRC_/Medical Research Council/United Kingdom